stockrow
Friday 6 November 2026
Export VKTX’s income statement to Excel — free account
Viking Therapeutics, Inc.
VKTX Healthcare Biotechnology
- EPS
- −91.6%
- Free cash flow
- −47.0%
Quarter to September 2026, against a year earlier
26.79
1.00
+3.88%
Follow VKTX
Alert me
Viking Therapeutics, Inc. (VKTX) Current ratio
Viking Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 7.3×, down 2.1× from fiscal 2025 (9.3×). Over the past ten years it has ranged from 2.2× (fiscal 2016) to 66.4× (fiscal 2018); the current reading is higher than 45% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 9.3× | (71.80%) |
| FY2024 | 33.1× | 72.44% |
| FY2023 | 19.2× | 152.15% |
| FY2022 | 7.6× | (68.27%) |
| FY2021 | 24.0× | 13.59% |
| FY2020 | 21.1× | (49.53%) |
| FY2019 | 41.8× | (37.00%) |
| FY2018 | 66.4× | 2,530.76% |
| FY2017 | 2.5× | 16.98% |
| FY2016 | 2.2× | (71.94%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 7.3× | 53.96% |
| Jun 2026 | 4.7× | (17.49%) |
| Mar 2026 | 5.7× | (38.71%) |
| Dec 2025 | 9.3× | (67.06%) |
| 43 more quarters | Free account |
Against its own ten years
Low 2.2×
High 66.4×
Ten-year median
19.2×
Current reading's percentile
45
Current ratio against peers
| Company | Current ratio |
|---|---|
| ELVN Enliven Therapeutics, Inc. compare | 64.1× |
| IRON Disc Medicine, Inc. compare | 24.1× |
| XENE Xenon Pharmaceuticals Inc. compare | 21.0× |
| PBLS Parabilis Medicines, Inc. compare | 17.9× |
| DYN Dyne Therapeutics, Inc. compare | 12.0× |
| CELC Celcuity, Inc. compare | 8.9× |
| VKTX Viking Therapeutics, Inc. | 7.3× |
| ACAD ACADIA Pharmaceuticals Inc. compare | 3.8× |
| TARS Tarsus Pharmaceuticals, Inc. compare | 2.0× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)